Literature DB >> 26238666

Thirty-day complications in rheumatoid patients following total knee arthroplasty.

Julio J Jauregui1, Bhaveen H Kapadia2, Anant Dixit2, Qais Naziri2, David J Hip-Flores2, Steven F Harwin3, Michael A Mont4.   

Abstract

Although total knee arthroplasty (TKA) is highly successful for patients with end-stage rheumatoid arthritis (RA), the risks and complications associated with surgery in this cohort are less defined. The objectives of our study were to analyze the demographic and perioperative factors of RA patients that may affect post-TKA outcomes, as well as to assess the 30-day complication rates compared to osteoarthritis patients. We retrospectively evaluated the National Surgical Quality Improvement Program (NSQIP) database from 2006 to 2012 to assess all patients who underwent a primary TKA and had a diagnosis of rheumatoid arthritis (n = 141) or primary knee osteoarthritis (n = 7125). We evaluated and compared the demographic factors, social factors, preoperative factors, operative factors, and postoperative complications. The RA cohort had a lower mean age and body mass index than patients in the OA group. There was also a significantly higher incidence of women and Hispanics in the RA cohort. There was a lower incidence of diabetes and hypertension requiring medication in the rheumatoid cohort, but also a higher incidence of bleeding disorders. The RA cohort had an increased proportion of patients requiring blood transfusions and had a longer mean length of stay. The incidence of pneumonia and postoperative bleeding that required transfusion was also higher in RA patients. Rheumatoid patients had higher rates of wound infections, pulmonary embolisms, and deep vein thrombosis; however, these findings were not significant. Although RA patients with end-stage knee arthritis may benefit from TKA, these patients should be preoperatively optimized to minimize complication risks.

Entities:  

Keywords:  Arthroplasty; Knee; Osteoarthritis; Rheumatoid arthritis

Mesh:

Year:  2015        PMID: 26238666     DOI: 10.1007/s10067-015-3037-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis.

Authors:  Bheeshma Ravi; Ruth Croxford; Simon Hollands; J Michael Paterson; Earl Bogoch; Hans Kreder; Gillian A Hawker
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

2.  Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patients.

Authors:  Alpesh N Amin; Greg Lenhart; Nicole Princic; Jay Lin; Stephen Thompson; Stephen Johnston
Journal:  Hosp Pract (1995)       Date:  2011-04

3.  Anaemia in rheumatoid arthritis: can we afford to ignore it?

Authors:  E Bloxham; V Vagadia; K Scott; G Francis; V Saravanan; C Heycock; M Rynne; J Hamilton; C A Kelly
Journal:  Postgrad Med J       Date:  2011-06-09       Impact factor: 2.401

4.  Factors influencing the incidence and outcome of infection following total joint arthroplasty.

Authors:  R Poss; T S Thornhill; F C Ewald; W H Thomas; N J Batte; C B Sledge
Journal:  Clin Orthop Relat Res       Date:  1984 Jan-Feb       Impact factor: 4.176

5.  Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes.

Authors:  Ottokar Stundner; Thomas Danninger; Ya-Lin Chiu; Xuming Sun; Susan M Goodman; Linda A Russell; Mark Figgie; Madhu Mazumdar; Stavros G Memtsoudis
Journal:  J Arthroplasty       Date:  2013-06-12       Impact factor: 4.757

Review 6.  Lower extremity arthroplasty in patients with inflammatory arthritis: preoperative and perioperative management.

Authors:  Susan M Goodman; Mark Figgie
Journal:  J Am Acad Orthop Surg       Date:  2013-06       Impact factor: 3.020

Review 7.  Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners.

Authors:  Mike D Van Manen; James Nace; Michael A Mont
Journal:  J Am Osteopath Assoc       Date:  2012-11

8.  Risk factors for total knee arthroplasty in rheumatoid arthritis.

Authors:  Shigeki Momohara; Eisuke Inoue; Katsunori Ikari; Koichiro Kawamura; So Tsukahara; Takeshi Mochizuki; Hiroe Toki; Motoko Miyawaki; Seiji Saito; Masako Hara; Naoyuki Kamatani; Hisashi Yamanaka; Taisuke Tomatsu
Journal:  Mod Rheumatol       Date:  2007-12-20       Impact factor: 3.023

Review 9.  A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis.

Authors:  Bheeshma Ravi; Benjamin Escott; Prakesh S Shah; Richard Jenkinson; Jas Chahal; Earl Bogoch; Hans Kreder; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2012-12

10.  Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis.

Authors:  George S Metsios; Antonios Stavropoulos-Kalinoglou; Gareth J Treharne; Alan M Nevill; Aamer Sandoo; Vasileios F Panoulas; Tracey E Toms; Yiannis Koutedakis; George D Kitas
Journal:  Arthritis Res Ther       Date:  2011-06-29       Impact factor: 5.156

View more
  3 in total

1.  Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Katelyn Brown; Kate Eckmann; Andrew Johannemann; Raymond D Wright; Leslie J Crofford
Journal:  J Clin Rheumatol       Date:  2018-12       Impact factor: 3.517

2.  Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis.

Authors:  Do-Kyung Lee; Hyun-Jung Kim; Dae-Hee Lee
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

Review 3.  Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades.

Authors:  Owen Taylor-Williams; Johannes Nossent; Charles A Inderjeeth
Journal:  Rheumatol Ther       Date:  2020-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.